Acarbose vs metformin for new-onset type 2 diabetes--author's reply

Lancet Diabetes Endocrinol. 2014 Feb;2(2):105. doi: 10.1016/S2213-8587(13)70219-5. Epub 2014 Feb 3.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Acarbose / therapeutic use*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Female
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Male
  • Metformin / therapeutic use*

Substances

  • Hypoglycemic Agents
  • Metformin
  • Acarbose